Park Medi World Intrinsic Value
Park Medi World (PARKHOSPS) median intrinsic value is ₹163.86 from 9 valuation models (range ₹70–₹465), vs current price ₹232.70 — -29.6% downside (Trading Above Calculated Value), margin of safety -42.0%. For current market price and key ratios, visit PARKHOSPS stock price BSE.
PARKHOSPS Valuation Methods Summary — DCF, Graham Number & P/E
Park Medi World intrinsic value across 9 models vs current price ₹232.70 — upside/downside and value range per method. Browse Park Medi World financial data for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹97.92 | ₹78.34 - ₹117.50 | -57.9% | EPS: ₹8.16, Sector P/E: 12x |
| Book Value Method | asset | ₹146.23 | ₹131.61 - ₹160.85 | -37.2% | Book Value/Share: ₹146.23, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹173.71 | ₹156.34 - ₹191.08 | -25.4% | Revenue/Share: ₹217.14, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹377.14 | ₹339.43 - ₹414.85 | +62.1% | EBITDA: ₹484.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹230.29 | ₹184.23 - ₹276.35 | -1.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹69.81 | ₹62.83 - ₹76.79 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹69.81 | ₹62.83 - ₹76.79 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹465.40 | ₹418.86 - ₹511.94 | +100.0% | ROE: 28.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹163.86 | ₹147.47 - ₹180.25 | -29.6% | EPS: ₹8.16, BVPS: ₹146.23 |
PARKHOSPS Intrinsic Value vs Market Price — All Valuation Models
Park Medi World fair value range ₹70–₹465 vs current market price ₹232.70 across 9 valuation models. Compare with Park Medi World value estimation to assess whether the stock is under or overvalued.
PARKHOSPS Intrinsic Value Analysis — Undervalued or Overvalued?
Park Medi World median intrinsic value ₹163.86, current price ₹232.70 — Trading Above Calculated Value by 29.6%, margin of safety -42.0%.
What is the intrinsic value of PARKHOSPS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Park Medi World (PARKHOSPS) is ₹163.86 (median value). With the current market price of ₹232.70, this represents a -29.6% variance from our estimated fair value.
The valuation range spans from ₹69.81 to ₹465.40, indicating ₹69.81 - ₹465.40.
Is PARKHOSPS undervalued or overvalued?
Based on our multi-method analysis, Park Medi World (PARKHOSPS) appears to be trading above calculated value by approximately 29.6%.
PARKHOSPS Financial Health — Key Ratios vs Industry Benchmarks
Park Medi World financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.29 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 28.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.78x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
PARKHOSPS Cash Flow Quality — Operating & Free Cash Flow
Park Medi World operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹191 Cr | ₹146 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹361 Cr | ₹234 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹199 Cr | ₹82 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹155 Cr | ₹31 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹223 Cr | ₹107 Cr | Positive Free Cash Flow | 7/10 |